APA (7th ed.) Citation

Moel, E. C. d., Rech, J., Mahler, M., Roth, J., Vogl, T., Schouffoer, A., . . . Woude, D. v. d. (2019). Circulating calprotectin (S100A8/A9) is higher in rheumatoid arthritis patients that relapse within 12 months of tapering anti-rheumatic drugs. Friedrich-Alexander-Universität Erlangen-Nürnberg. https://doi.org/10.1186/s13075-019-2064-y

Chicago Style (17th ed.) Citation

Moel, Emma C. de, et al. Circulating Calprotectin (S100A8/A9) Is Higher in Rheumatoid Arthritis Patients That Relapse Within 12 months of Tapering Anti-rheumatic Drugs. Erlangen ; Nürnberg: Friedrich-Alexander-Universität Erlangen-Nürnberg, 2019. https://doi.org/10.1186/s13075-019-2064-y.

MLA (9th ed.) Citation

Moel, Emma C. de, et al. Circulating Calprotectin (S100A8/A9) Is Higher in Rheumatoid Arthritis Patients That Relapse Within 12 months of Tapering Anti-rheumatic Drugs. Friedrich-Alexander-Universität Erlangen-Nürnberg, 2019. https://doi.org/10.1186/s13075-019-2064-y.